Why ASX Cannabis Stocks are Down — Should You Invest?

It’s been a tough year for ASX cannabis stocks with many companies shedding value over a 12-month window. Only Althea has emerged from the last year with a gain to show for it. It’s worth taking a look at the ETFMG Alternative Harvest ETF chart to see what’s happening to cannabis stocks globally....

ASX Cannabis Stocks Wrap: MGC, BDA Elixinol News

Today, we look at the latest Elixinol news, along with recent announcements out of MGC and BOD. We conclude that Elixinol could encounter support in the coming weeks or months. Meanwhile, MGC and BOD remain exciting but more speculative cannabis plays.

New German Deal Sends Elixinol’s Share Price 5.86% Higher

Elixinol has focused much of its operational efforts to rapid global expansion over the past couple of years. In 2019 alone, the company has managed to expand operations across Europe, including the Netherlands, Spain and United Kingdom (a cannabis market predicted to be worth €115.7 billion by 2028). It entered the New Zealand market and significantly expanded US operations via capital raisings and acquisitions.
Money Morning Australia